SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-019895
Filing Date
2022-01-27
Accepted
2022-01-27 16:53:04
Documents
15
Period of Report
2022-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d291411d8k.htm   iXBRL 8-K 26659
2 EX-99.1 d291411dex991.htm EX-99.1 14348
3 EX-99.2 d291411dex992.htm EX-99.2 14115
7 GRAPHIC g291411g61r84.jpg GRAPHIC 3146
  Complete submission text file 0001193125-22-019895.txt   193353

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bhc-20220127.xsd EX-101.SCH 2534
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20220127_lab.xml EX-101.LAB 18035
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20220127_pre.xml EX-101.PRE 11326
9 EXTRACTED XBRL INSTANCE DOCUMENT d291411d8k_htm.xml XML 3449
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 22563843
SIC: 2834 Pharmaceutical Preparations